|
🐜
|
Facial-muscle weakness, speech disorders and dysphagia are common in patients with classic infantile Pompe disease treated with enzyme therapy
11 auth.
C. Gelder,
C. I. Capelle,
B. Ebbink,
I. Moor-van Nugteren,
J. Hout,
M. Hakkesteegt,
...
P. Doorn,
I. Coo,
A. Reuser,
H. D. Gier,
A. Ploeg
|
6 |
2011 |
6
🐜
|
